AGENUS INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGENUS INC stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $644.00K.
- AGENUS INC stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $34.00K.
- AGENUS INC stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $14.00K, a 99.54% decline year-over-year.
- AGENUS INC stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $3.07M, a 232.47% increase year-over-year.
- AGENUS INC stock issued during period, value, stock options exercised for fiscal 2016 was $729.80K, a 58.69% decline from fiscal 2015.
- AGENUS INC stock issued during period, value, stock options exercised for fiscal 2015 was $1.77M, a 1115.89% increase from fiscal 2014.
- AGENUS INC stock issued during period, value, stock options exercised for fiscal 2014 was $145.31K, a 860.44% increase from fiscal 2013.
- AGENUS INC stock issued during period, value, stock options exercised for fiscal 2013 was $15.13K, a 42.65% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $644.00K 10-Q · filed 2026-08-07 | |
| 2024-06-30 | $34.00K 10-Q · filed 2025-11-10 | |
| 2022-06-30 | $14.00K 10-Q · filed 2023-11-09 | |
| 2021-06-30 | $3.07M 10-Q · filed 2022-11-08 | |
| 2020-06-30 | $924.00K 10-Q · filed 2021-11-09 | |
| 2016-12-31 | $729.80K 10-K · filed 2017-03-16 | |
| 2015-12-31 | $1.77M 10-K · filed 2017-03-16 | |
| 2014-12-31 | $145.31K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $15.13K 10-K · filed 2016-03-15 | |
| 2012-12-31 | $26.38K 10-K · filed 2015-03-16 | |
| 2011-12-31 | $1.44K 10-K · filed 2014-03-07 | |
| 2010-12-31 | $719.00 10-K · filed 2013-03-18 | |
| 2009-12-31 | $141.31K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |